McKesson Designated by CMS as 2022 Qualified Clinical Data Registry

IRVING, Texas, Feb. 8, 2022 — For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR).

Read the source article at Targeted Oncology
2022-02-09 04:51:00